Tamlin Bason, Legal Associate, Bloomberg Analyst
Manus Cooney, American Continental Group
Dr. Hans Sauer, PhD, JD, Associate General Counsel Intellectual Property, Biotechnology Industry Organization (BIO)
Ryan Triplette, Director of Government Relations for the Intel Corporation, Franklin Square Group
Jayson D. Pankin, Founder, President, and the Chief Executive Officer, Autoharvest Foundation
John Carney, Director of Commercialization & Licensing, Delphi Automotive Systems, LLC.
Frank MacKenzie, Senior Intellectual Property Counsel, Mobility, Autonomous Vehicles, Safety, and Electronics, Ford Motor Company
Justin Pierce, Chair of Intellectual Property Division, Venable LLP
David Strickland, Counsel, Self-Driving Coalition for Safer Streets; Former Head, US National Highway Transportation Safety Administration
Alexander Putin, Communications & IT Section, UN Secretariat-Procurement Division
Timothy P. Ribelin, Healthcare Attorney, Husch Blackwell LLP
Jayson Slotnik, Principal and Founding Member, Health Policy Strategies, LLC
Kevin Jakel, CEO, Unified Patents
Tim Seeley, Chief Counsel, Post Grant Proceedings, Intellectual Ventures
Joseph Sommer, VP, AT&T Intellectual Property, Inc. – LES member Big Data, Analytics and Security
The last decade has seen increases in life science partnerships between industry and academic research. Simultaneously, there is an historic and potential future declines in basic research funding at the federal level. This workshop will explore the potential for partnerships that support non-profit research, including priorities and interests of industry funders, the handling of IP rights, and successful structures for partnerships. The workshop will include discussion on the following topics:
Participants will learn current practices in large-scale industry-non-profit research partnerships, the benefits and conflicts inherent in them, and preferred methods for creating and sustaining these partnerships.
Michael Perham, Head of Technology Transfer, HHMI/Janelia Research Campus
Gillian Fenton, Senior Counsel, Vaccines Legal Operations, GSK
Dave Greenwald Ph.D., Director of Corporate Relations, Johns Hopkins
Thomas Marron, Pharmaceutical Strategy and Operations, Eli Lilly and Company
Michael Straightiff, Executive Director, UVA Licensing & Ventures Group, University of Virginia
The panel will focus on educating the audience on ITC Investigations. The presentation will provide a general overview of ITC litigation; identify key issues to consider when deciding on which venue to pursue; identify specific factors to consider when establishing necessary proofs; and discuss how current events at the ITC may impact future investigations. The following topics will be addressed during the panel/presentation:
Michael Milani, Managing Director, Ocean Tomo
Tom M. Schaumberg, Partner, Adduci Mastriani & Schaumberg LLP
Moderator: Gregory Jaeger, Special Counsel, Stroock & Stroock & Lavan LLP
Nicoletta Giordani, Assistant Director, Business Analysis and Mitigation Strategy (BAMS), U.S. Department of Defense
John Pisa-Relli, Managing Director, Global Trade Compliance, Accenture
Marcia Chang, Managing Director, Intellectual Property Sales and Licensing, Hewlett Packard Enterprise
David R. Jarczyk, CLP, President & CEO, KtMINE
George P. Koomullil, CEO, Relecura Inc
Justin Lewis, Managing Director, Ocean Tomo, LLC
Lynne Weber, Managing Director, Dunn & Phelps, LLC
Richard Ciamacca, General Counsel, Amring Pharmaceuticals
Erika Geimonen, Ph.D., VP of Business Development, Amring Pharmaceuticals
Allen Lefkowitz, Managing Director, Torreya Partners
Jay P. Lessler, Partner, Blank Rome LLP
James R. Staiger, Partner, Blank Rome LLP
Discussion on the current state of IP Judicial Policy, PTAB, District, CAFC and Supreme Court, how they are impacting licensing and IP in the US. Bloomberg will give a high level description of key Judicial impacts on damages, patentability, etc. and panelists will give their thoughts on how they viewed making policy from the bench and now how they see judicial policy impacting innovation, licensing, etc. from off the bench.
Matt Larson, Tech Litigation Analyst, Bloomberg
Deanna Tanner Okun (Former ITC Chair), Partner, Adduci Mastriani & Schaumberg LLP
Former Chief Federal Circuit Judge Randall R. Rader
Discuss President-elect Donald Trump’s campaign promise to cut red tape at the Food and Drug Administration and speed up the approval of lifesaving medications. As he was President of a company that he took IPO, we should request him to position his comments to discuss implications / impact for deal making assumptions, due diligence, and valuation of FDA approved products in light of the change in administration.
Joe Gulfo, MD, MBA, Author, Executive Director, Fairleigh Dickinson University
We’ve all heard enough about cybersecurity to be scared out of our minds. As the internet of things takes hold, data—important, proprietary, personal data—is subject to attack and ransom as it passes through all types of devices on its way to the cloud. Whether involving life-critical medical devices or ordinary household appliances, how we license, transfer, and protect data is more important than ever before. If we fail, our personal data, our company’s data, our client’s data—not to mention the future of our business reputation and growth—are all at risk. But there is hope! Hear from a panel of experts representing government, industry, security, and legal sectors as they discuss the latest cybersecurity trends, new, sophisticated behavior-analytics tools that can prevent attacks before they occur, and practical steps victims can take to minimize the damage, stop the wrongdoers, and be responsible community members. Come afraid and leave with a changed mindset ready to tackle cybersecurity with confidence.
Mark Schildkraut, Associate General Counsel, IP and Cybersecurity, Becton Dickinson
Shamoil Shipchandler, Regional Director, U.S. Securities and Exchange Commission
An industry leading panel on intellectual property and licensing issues associated Augmented Reality (AR) and Virtual Reality (VR) including the related devices, software, and designs. Projected to exceed $150B by 2020, AR/VR is not only a patent centric minefield, but it contains new media combining Hollywood with Madison avenue, requiring an entirely unique approach to the associated intellectual property and licensing.
Stephen Kabakoff, Partner, Finnegan Henderson
Charles Huston, Partner, Solomar
Nicoletta M. Kennedy, Associate, Kilpatrick Townsend & Stockton LLP
Peter Christensen, Manager, Technology Commercialization, Pacific Northwest National Laboratory
Ariel Oseasohn, Energy Transactions Analyst, Kilpatrick Townsend & Stockton LLP
Ronald J. Schutz, Managing Partner-New York, Robins Kaplan LLP
Alex Tang, Licensing and Commercialization Manager, Gas Technology Institute
Numerous industries are seeing increased reliance on (and litigation regarding) non-patent assets, particularly trademarks. However, building brands involves more than merely obtaining trademark registrations. Hear from industry professionals on how to build brands and create value.
Doug Bania, Principal, Nevium IP Solutions
Nicole Pope, Counsel, Talent and Licensing, Feld Entertainment (Ringling Bros, Monster Jam, Disney on Ice)
Boston is a hub for activity in the Life Science industry due to the presence of leading universities, major research hospitals, venture capital resources, global corporations and an ever-expanding network of start-ups. Because Boston is viewed as an innovation center, some have argued that companies must move to Boston to succeed in this industry. This workshop will involve a candid discussion with various industry players to assess the impact of geography on deal making activity.
Faith Charles, Partner, Thompson Hine LLP
Ranch Kimball, Managing Director of CIC, Secretary of Economic Development
Arthur M. Pappas MBA, Chief Executive Officer and Managing Partner, Pappas Capital, LLC
Dr. Carl Spana, PhD, Chief Executive Officer, Palatin Technologies Inc
Efrat Kasznik, President, Foresight Valuation Group
Andy Forsberg, Intellectual Property and Patent Licensing, Microsoft
Dmitry Milikovsky, VP Business Development, Wireless Connectivity
Sankara Narayanan Ph.D., VP Business Development, Relecura Inc
Joseph Sommer, VP, AT&T Intellectual Property, Inc.
Dr. Jerry Wald, Sr. Director, Intellectual Asset Protection and Program Management Services